Financials

News Ideas Discussions Technicals Forecast Seasonals

4VRTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of VERTEX PHARMACEUTICALS

Total assets of 4VRTX for Q3 24 is 19.97 B EUR, 6.28% more than the previous Q2 24. And total liabilities increased by 18.68% in Q3 24 to 5.94 B EUR.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—